Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies-Reference-Cited by-同舟云学术

Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies

Published:2021-12 Issue: Volume:140 Page:1-11
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Le Stang Marie-Bénédicte,Gleeson Patrick J.,Daha Mohamed R.,Monteiro Renato C.,van Kooten C.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference157 articles.

1. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney;Abe;Kidney Int.,1998

2. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells;Amore;J Am Soc Nephrol.,2001

3. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies;Banda;Arthritis Rheum.,2008

4. Evaluating a new international risk-prediction tool in IgA nephropathy;Barbour;JAMA Intern. Med.,2019

5. Composition of mesangial deposits in IgA nephropathy: complement factors;Bene;Nephron.,1987

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy;Scientific Reports;2024-07-13

2. Looking for a new role of known players: the additional value of plasmatic C3 and C4 in predicting IgA Nephropathy prognosis, an observational study;2024-05-09

3. Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathy;Nephrology Dialysis Transplantation;2023-10-10

4. Challenges in IgA Nephropathy Management: An Era of Complement Inhibition;Kidney International Reports;2023-09

5. Pathophysiology and clinical manifestations of immune complex vasculitides;Frontiers in Medicine;2023-03-03